entity

TDP-43_pathology

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TDP-43_pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

5Hypotheses

6Analyses

0Outgoing

1Incoming

0Experiments

6Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (1)

Source	Relation	Type	Str
MMP9	generates	gene	0.50

Targeting Hypotheses (5)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Glial Neuroinflammatory Amplification by TDP-43 Pathology	0.680	neurodegeneration	What mechanisms underlie TDP-43's contri
TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Ca	0.678	neurodegeneration	What mechanisms underlie neuronal resist
TDP-43 Pathology Creates a Distinct Epigenetic Clock "Signat	0.483	-	Epigenetic clocks as biomarkers for Alzh
Necroptosis-cGAS Feedforward Loop Converts TDP-43 Pathology	0.460	neuroinflammation	How does chronic cGAS/STING activation d
DNA Damage Repair Dysfunction Creating TDP-43 Pathology Feed	0.430	neurodegeneration	How does APOE4 mechanistically increase

Mentioning Analyses (6)

Scientific analyses that reference this entity

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.776

What mechanisms underlie TDP-43's contribution to cognitive impairment severity

neurodegeneration | 2026-04-08 | 5 hypotheses Top: 0.680

What upstream mechanisms cause TDP-43 to trigger mPTP opening and can this be th

neurodegeneration | 2026-04-08 | 5 hypotheses Top: 0.693

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

neurodegeneration | 2026-04-07 | 3 hypotheses Top: 0.595

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer'

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.580

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (6)

Multi-agent debates referencing this entity

What are the mechanisms by which microglial senescence contributes to ALS pathol

active · Rounds: 6 · Score: 0.75 · 2026-04-26

While the study establishes TDP-43 triggers mtDNA release via mPTP to activate c

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

The abstract identifies APOE4 association with increased TDP-43 pathology but th

closed · Rounds: 4 · Score: 0.61 · 2026-04-21

TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leadi

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

While the study demonstrates TDP-43 triggers mPTP-mediated mtDNA release, the mo

closed · Rounds: 4 · Score: 0.77 · 2026-04-21

AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-4

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

Related Research

Hypotheses and analyses mentioning TDP-43_pathology in their description or question text

No additional research found

TDP-43_pathology

Understanding Entity Pages

Outgoing (0)

Incoming (1)

Targeting Hypotheses (5)

Mentioning Analyses (6)

What are the mechanisms by which microglial senescence contributes to ALS pathol

What mechanisms underlie TDP-43's contribution to cognitive impairment severity

What upstream mechanisms cause TDP-43 to trigger mPTP opening and can this be th

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer'

What determines the specificity of TDP-43-induced mitochondrial DNA release for

Experiments (0)

Related Papers (0)

Debates (6)

What are the mechanisms by which microglial senescence contributes to ALS pathol

While the study establishes TDP-43 triggers mtDNA release via mPTP to activate c

The abstract identifies APOE4 association with increased TDP-43 pathology but th

TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leadi

While the study demonstrates TDP-43 triggers mPTP-mediated mtDNA release, the mo

AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-4

Related Research